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Cannabis and caries — 
does regular cannabis use 
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Summary The use of cannabis by adoles-
cents in Switzerland has almost doubled in 
the past decade. Empirical observations in 
private dental practices indicate that cannabis 
users have more carious lesions than those 
who do not use cannabis. The aim of this 
study was to investigate the hypothesis that 
regular cannabis use increases the risk of car-
ies because of hyposalivation or lifestyle.
Forty-three regular cannabis users were en-
rolled in the test group and 42 tobacco smok-
ers were used as a negative control group. All 
subjects were 18–25 years old. Data were 
obtained using a standardized questionnaire 
and a clinical examination.
There was no signiﬁcant difference between 
groups in decayed and ﬁlled surfaces (DFS), 
saliva ﬂow rate and plaque and gingival indi-
ces. The cannabis group had, however, sig-
niﬁcantly higher DS (decayed surface) values 
(p = 0.0001) and signiﬁcantly lower frequen-
cies of daily tooth brushing and dental control 
visits (p < 0.0001) than the control group. Ad-
ditionally, the cannabis group reported a 
 signiﬁcantly higher consumption of sugar-
containing beverages than the control group 
(p = 0.0078). To obtain more objective data 
relations, the DS values of male cannabis us-
ers were also compared with those of Swiss 
military recruits found in another study. The 
cannabis users had more caries on smooth 
surfaces than the military recruits.
Although comparison with epidemiological 
data suggested that the prevalence of caries 
on smooth surfaces is elevated in cannabis 
users, DFS data indicated that cannabis users 
do not have an increased risk of caries. Life-
style combined with short-term hyposalivation 
after delta-9-tetrahydrocannabinol consump-
tion is the most probable cause of the high 
prevalence of caries on smooth surfaces in 
cannabis users. Further studies are needed to 
investigate the effects of cannabis use on oral 
health.
Introduction
The use of cannabis is common in Europe. One out of ﬁve 
adults has used cannabis at least once in his or her lifetime. 
Once-in-a-lifetime use of cannabis is particularly prevalent 
among younger members of the population because 44% of 
15–34-year-olds report using cannabis once. Estimates of the 
actual use of cannabis (use during the past 12 months) in 
15–34-year-olds in Europe vary from 5%–20%. On a global 
basis, regular use of cannabis is highest in Canada and Spain 
(> 15%) and Switzerland (18.3%) (European Monitoring Centre 
for Drugs and Drug Addiction [EMCDDA] 2002, Bundesamt 
für Statistik 2004).
During the past decade, regular cannabis use by young 
people (15–24 years old) has increased in Switzerland. From 
1992 to 2002, cannabis consumption almost doubled (from 
9.8% to 16.3% in males and from 4.3% to 7.7% in females) 
(Bundesamt für Statistik 2004). Among 15–16-year-old Swiss 
pupils, 49.9% of males and 39.1% of females had at least a 
once-in-a-lifetime experience with cannabis. The probability 
of young people using cannabis has increased since 1986. 
Males are more likely to use cannabis than females (Schmid et 
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al. 2003); 41% of male and 33% of female 14–16-year-old Swiss 
teenagers reported an experience with cannabis. Twenty per-
cent of pupils reported using cannabis in the previous 30 days, 
6.5% had used cannabis once or twice, 9.8% had used can-
nabis 3 to 39 times and 2.2% had used cannabis 40 times or 
more (split by gender: males 3.1%, females 1.3%) (Gmel et al. 
2003).
Narring and coworkers differentiated between genders and 
between students and apprentices. Among 20-year-old males, 
60% of apprentices and 73% of students had at least a once-
in-a-lifetime-experience with cannabis. The majority of young 
people in Switzerland between the ages of 16 and 20 has used 
cannabis occasionally and 4% of females and 13% of males use 
it on a daily basis (Narring et al. 2003).
The cannabis plant, Cannabis sativa, originated in central 
Asia and was introduced into India in the 8th century BC, where 
it was used for religious ceremonies and medical purposes. 
Subsequently, cannabis was widely used to treat gastric com-
plaints, headaches, coughing, hepatitis, gout, “hard tumors”, 
tetanus and rabies. In the 20th century, the pharmaceutical 
importance of cannabis diminished because of the invention 
of drugs and vaccinations speciﬁc for many of the above-
mentioned illnesses.
Cannabis contains 483 natural substances belonging to 
19 classes of chemicals. Cannabis contains 66 cannabinoids. 
The most potent psychoactive substance is delta-9-tetrahydro-
cannabinol (THC). The effects of most of these substances on 
the human body are unknown. Although cannabis has medi-
cal potential, further knowledge on its biological effects and 
on appropriate forms of application is needed (Grotenhermen 
2001).
Cannabis is inhaled by smoking and is often mixed with 
tobacco. It can also be added to food. Cannabis is consumed 
in three main forms: marijuana (dried weeds and blossoms), 
hashish (pollen and resin) and hashish oil. The concentration 
of THC is 9.6% in marijuana, 14.8% in hashish and 66.4% 
in hashish oil (Schläpfer 2005). The most common forms of 
cannabis use in Switzerland are marijuana (44%), hashish 
(22%) and a mixture of both (34%) (Müller et al. 2001). When 
cannabis is smoked, effects occur within 2 to 3 minutes, peak 
within 10 to 20 minutes and diminish after 2 hours (Darling 
2003).
Cannabis smoke contains carcinogens similar to those in 
tobacco smoke but contains no nicotine (Elsohly 2001). One 
marijuana joint deposits four times as much tar in the respira-
tory tract as a tobacco cigarette of the same weight (Tashkin 
1999). According to Hall & Macphee (2002) “the experimental 
and epidemiological evidence of the cancer risks of cannabis 
use is still too meagre to warrant strong conclusions, but it 
raises concerns that for reasons of prudence should be com-
municated to cannabis users on public health grounds”.
The THCs of synthetic, biological or endogenous cannabi-
noids exert their effects throughout the body by interacting 
with receptors of the cannabinoid system, which was ﬁrst 
identiﬁed in invertebrates and mammals. The human endog-
enous cannabinoid is called anandamide; its effects are similar 
to those of THC but are much weaker. Neuronal receptors 
called CB1s are located in the central nervous system (cerebel-
lum, frontal cerebrum and hippocampus). As there are very 
few CB1s in the brainstem, vital functions are not affected by 
the use of cannabis. Therefore, a lethal dose of cannabis is 
improbable. Nevertheless, cannabis abuse has many adverse 
psychological and physiological effects (Table I).
The effects of cannabis are complex. Adolescents, in whom 
the nervous system is still developing, are especially vulnerable 
(Ehrenreich et al. 1999, Wilson and Nicholl 2001). Hypo-
salivation is of great interest to dental professionals for its 
negative effect on oral health (Imfeld 1984).
A search of the PubMed database, a service of the U. S. Na-
tional Library of Medicine and the National Institutes of 
Health, using “cannabis” or “marijuana” and “caries” as key 
words returned only seven references. Cho (2005) and Darling 
& Arendorf (1992) reviewed the scientiﬁc literature on the 
effects of cannabis on oral health, including dry mouth. 
 Madinier (2002) discussed the illicit drugs that are used by 
regular drug users when they have toothache. Pallasch (1987) 
described the effects of drug abuse on the oral cavity in general. 
Di Cugno (1979) studied vitamin levels and oral status in 
51 amphetamine and cannabis users in Buenos Aires, Argentina. 
He mentioned that xerostomia was a side effect of these drugs, 
but did not report on how this result was obtained. Silverstein 
et al. (1978) investigated a group of 206 people living in a 
commune in the USA in which cannabis and tobacco were 
used in addition to other drugs. The control group consisted 
I Psyche and perception Sedation, euphoria, dysphoria, anxiety increase and decrease, depersonalization, intense sensoric perception,  
  increased sexual sensation, changed time-relevance, hallucinations
II Cognition and the  Fragmented thinking, distorted short-term memory and attention, associated thinking, increased creativity, ataxia, 
 psychomotor system woolly language, better or worse movement coordination, decreased hyperkinetic movement distortion
III Nervous system Analgesia, muscle relaxation, increased appetite, emesis, anti-emesis, neuroprotection in ischemia and hypoxemia
IV Body temperature Decreased body temperature
V Cardiovascular system Tachycardia, increased heart load and oxygen need, vasodilatation, orthostatic hypotension, hypertension while  
  lying, inhibition of thrombocytic aggregation
VI Eye Conjunctival redness, decreased tear water, decreased intraocular pressure
VII Respiratory system Bronchodilatation, hyposalivation with a dry mouth
VIII Digestive system Decreased intestinal motility and gastric emptying
IX Endocrine system Effect on LH, FSH, testosterone, prolactin, growth hormone, TSH, glucose homeostasis, decreased spermiogenesis,  
  decreased sperm motility, menstrual cycle interruptions and inhibited ovulation
X Immune system Impairment of cellular and humoral immunity, immune stimulation, inhibition of inﬂammation
XI Embryo development Inhibition of growth, reduction in fetal and early brain development, impairment of cognitive capacity
XII Genome and cancer Antineoplastic activity, inhibition of the synthesis of DNA, RNA and proteins
Tab. I Psychological and physiological effects of cannabis (Grotenhermen 2001)
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of 68 people who did not smoke tobacco and did not live in a 
commune. The seventh report identiﬁed by the PubMed 
search, Phytonicides in Dentistry by Soldan (1953), was pub-
lished in the Czech language and an English abstract was not 
available.
To our knowledge, our study is the ﬁrst clinical investigation 
on the speciﬁc effects of cannabis use on oral health in smok-
ers. The hypothesis tested in this study, i. e., that regular can-
nabis use increases the risk of caries, originated from empirical 
experience in dental private practice. Potential explanations 
are that the increased risk of caries is caused by THC-associated 
hyposalivation or lifestyle.
Material & Methods
The study was approved by the SPUK ethics commission (Spe-
zialisierte Unterkommission der Kantonalen Ethikkommssion, 
Zürich) in April 2005 (StV 05/04). Informed consent was ob-
tained from all participants.
According to Article 15 of the Swiss Health Statute, the in-
vestigators were not requested to report the subjects who used 
or abused cannabis to the police, and all information was 
conﬁdentially because there was no evidence of delinquency 
among the subjects (Bundesgesetz über Betäubungsmittel und 
Psychotrope Stoffe 812.121 [BetmG] 2007).
Participants were recruited through advertisements in free 
daily newspapers, short presentations at high schools and 
vocational schools, ﬂyers and regional radio appeals. Partici-
pants were also encouraged to recruit their friends.
Cannabis users were recruited before deﬁning the inclusion 
criteria for the control group because neither clinical data nor 
habits of cannabis users were well known. When examining 
the test group it was observed that all of them additionally 
smoked tobacco on a regular basis (at least ten cigarettes per 
day). In order to get similar group parameters with cannabis 
use as the main difference, tobacco use was deﬁned as an inclu-
sion criterion for the control group as well. If non-smokers had 
been chosen as a control group tobacco smoking would have 
become a confounding factor for the evaluation of the effect 
of cannabis use.
Inclusion criteria for the test group (cannabis users, group A):
 (i) age 18 to 25 years,
 (ii) good general health,
 (iii) cannabis use (at least once per week),
 (iv) duration of cannabis use (at least two years).
Inclusion criteria for the control group (cannabis nonusers, group B):
 (i) age 18 to 25 years,
 (ii) good general health,
 (iii) no cannabis use,
 (iv) tobacco use (at least ten cigarettes per day),
 (v) duration of tobacco use (at least two years).
Exclusion criteria for both groups:
 (i) medical conditions affecting the oral cavity,
 (ii) use of other illicit drugs,
 (iii) pregnancy.
All participants completed a questionnaire to obtain data on 
demographics, psychological history, health status, dietary 
habits and daily oral hygiene. The cannabis group was also 
questioned about the frequency of drug use, their favorite form 
of cannabis, the age at which they ﬁrst experienced cannabis, 
whether they experienced a dry mouth after smoking canna-
bis, whether they would change their drug habits if they were 
associated with an increased risk of caries, and whether they 
would stop using cannabis if it was associated with an in-
creased risk of developing cancer.
The participants were clinically examined by one researcher 
(M. S.). Two bitewing radiographs were taken. These were as-
sessed by a second researcher (C. I.). The oral mucosa was in-
vestigated for abnormalities. Plaque and gingival indices (Löe 
1967) were measured buccally in the 1st and 4th quadrants and 
orally in the 2nd and 3rd quadrants. The level of decayed and 
ﬁlled surfaces (DFSs) (Klein et al. 1938) was determined. The 
M (missed surfaces) factor was omitted because third molars 
and teeth extracted for orthodontic reasons were not in-
cluded in the analysis. Decayed lesions (D) were deﬁned as 
dentine lesions detected radiographically or clinically. The 
DFS data of group A was compared with DFS data obtained 
from an epidemiological survey of Swiss military recruits in 
2006 (Menghini et al., unpublished). The stimulated saliva ﬂow 
rate was measured using a high-precision scale and saliva pH 
and buffer capacity were measured using an indicator system 
(pH 6.4–8.0; Merck KGaA, D-64271 Darmstadt) and a buffer 
analysis kit (CRT®, Ivoclar-Vivadent, FL-9494 Schaan), respec-
tively.
Participants were not charged for the dental examination 
and were given duplicates of the bitewing radiographs. All par-
ticipants received detailed information about their oral status 
and individual advice on prophylaxis (ﬂuoride, oral hygiene, 
and nutrition). Patients were informed about the effects of 
regular oral hygiene, ﬂuoridated toothpaste and gel and effec-
tive tooth brushing methods. If the patients reported unfavor-
able dietary habits (e. g., intake of beverages or food with a high 
sugar content), they were informed as to how their diet could 
be improved.
Urine samples were not obtained from the participants be-
cause self-reported cannabis use is not distorted by denial ten-
dencies (Gmel 1998).
Statistical analysis
As groups A and B were not paired in respect of gender, the 
data were only analyzed descriptively. Differences between the 
control and test groups within genders were analyzed using 
the Mann–Witney and chi-squared tests.
Results
Gender, age, education and tobacco use
Forty-three participants were included in the test group (can-
nabis users, group A) and 42 were included in the control 
group (tobacco smokers, group B). In group A, 28 subjects were 
male (65%) and 15 were female (35%); in group B, 14 subjects 
were male (33%) and 28 were female (67%). The average age 
of participants was 22.6 years for group A and 23.2 years for 
group B.
Seventy percent of subjects in group A and 60% of subjects 
in group B were apprentices; 18% of subjects in group A and 
33% of subjects in group B attended university or college; 12% 
of subjects in group A and 7% of subjects in group B were neither 
apprentices nor students.
Fifty percent of subjects in group A and 56% of subjects in 
group B smoked 10 cigarettes per day; 50% of subjects in group 
A and 33% of subjects in group B smoked 10–20 cigarettes per 
day; 9% of subjects in group B smoked more than 20 cigarettes 
per day.
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Frequency of daily tooth brushing
The frequency of daily tooth brushing is shown in Table II. 
Group A brushed signiﬁcantly less than group B (p < 0.0001, 
chi-squared test).
Frequency of dental visits
Twenty-one percent of subjects in group A and 74% of subjects 
in group B visited their dentist annually. Reasons for irregular 
or rare visits given by the remaining 79% of subjects in group 
A were anxiety (10%), no interest (25%) or ﬁnancial con-
straints (65%). The difference in the frequency of dental visits 
between groups was signiﬁcant (p < 0.0001, chi-squared test). 
There was no signiﬁcant difference in the frequency of dental 
visits between genders within groups.
Sweet snacks
Thirty-seven percent of subjects in group A and 43% of subjects 
in group B consumed one sugar-containing snack per day. Fifty-
one percent of subjects in group A and 40% of subjects in 
group B ate 2–4 high-sugar snacks per day. There was no sig-
niﬁcant difference in the frequency of high-sugar snack con-
sumption between groups.
Beverages
Daily beverage consumption was categorized as water/tea (with-
out sugar), soft drinks (carbonated drinks) and sweet drinks 
(iced tea, sweetened coffee or tea, and orange juice) (Table III). 
The beverage consumption of groups A and B was signiﬁcantly 
different (p = 0.0078, chi-squared test).
Cannabis use
The participants of group A had their ﬁrst experience with 
cannabis at a mean age of 15 years. Of the participants in group 
A, 2.3% used cannabis once weekly; 25.6% used it several times 
per week, 34.9% used it once per day and 37.2% used it several 
times per day. Seventy-nine percent used cannabis only in the 
evening and 21% began using cannabis in the morning or at 
noon. All subjects used cannabis by smoking it; 93% smoked 
marijuana (dried leaves) and 7% smoked hash (resin and pol-
len). Ninety-ﬁve percent smoked cannabis mixed with tobacco 
and 5% smoked pure cannabis. The incidence of hunger, thirst 
and consumption of food and drink after the use of cannabis 
are presented in Table IV.
Oral hygiene
Seventy-two percent of group A subjects cleaned their teeth 
after using cannabis and 28% did not. Reasons given for ne-
glecting oral hygiene were “too tired” (84%) and “didn’t feel 
like doing that” (16%).
Willingness to change habits
When asked whether they would change their habits if it were 
proven that the risk of caries is increased by cannabis use, 79% 
of the participants of group A answered yes and 21% answered 
no. Forty-four percent of those who answered in the afﬁrma-
tive indicated that they would brush their teeth immediately 
after using cannabis, 44% indicated that they would improve 
their oral hygiene, 9% indicated that they would consume less 
sweets and 3% indicated that they would reduce their use of 
cannabis. When asked if they would stop smoking cannabis if 
it were proven that the risk of developing cancer is increased 
by cannabis use, 97% answered no and 3% answered yes.
Clinical results
The gingival indices, plaque indices and stimulated saliva ﬂow 
rates for groups A and B were 1.26 and 1.11, 1.21 and 0.90 and 
1.9 and 1.8 ml/min, respectively; there was no signiﬁcant dif-
ference between groups. In both groups, saliva buffer capacity 
was intermediate and saliva pH was 7.0. The incidence of DFS 
is presented in Table V. The incidence of DFS was not signiﬁ-
cantly different between groups (p = 0.2112) when both gen-
ders were included in the analysis but differed when only 
males were included in the analysis (p = 0.0051, Mann–Witney 
test).
The incidence of decayed surfaces (DS) is also presented in 
Table V. The difference between groups was highly signiﬁcant 
Daily tooth brushing Group A Group B                              Gender 
   Males A Females A Males B Females B
     0  5 2 7 0 7 0
     1  42 2 43 40 7 0
     2  44 65 39 53 79 57
     3  9 31 11 7 7 43
Tab. II Daily tooth brushing in groups A and B (%)
 Main beverage Group A Group B
 Water/tea 62.8 88.1
 Soft drinks 16.3 0.0
 Sweet drinks 20.9 11.9
Tab. III Beverage consumption in groups A and B (%)
 Hungry after Type of food Thirsty after Type of drink Dry mouth after Duration of 
cannabis use consumed after cannabis use consumed after using cannabis dry mouth 
  using cannabis  cannabis use
 no 12   no 9   no 16
 yes 88 sweet 63 yes 91 water 69 yes 84 1 h 81
   salty 37   soft drinks 10   2–6 h 19
   sour 0   sweet drinks 21    
Tab. IV Behavior after using cannabis (%)
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(p < 0.0001, Mann–Witney test). The number of DS in males dif-
fered between groups as did those of females (males, p = 0.0001; 
females, p = 0.0016; Mann–Witney test).
The clinical examination revealed a high prevalence of car-
ies on smooth surfaces, which according to epidemiological 
data is uncommon for this age group in Switzerland. This was 
analyzed in greater detail by subdividing data according to the 
state of the lesion (initial [D1–2] or dentine [D3–4]) and its 
location (molars or front teeth) (Table VI). As groups consisted 
of small numbers of subjects and were not paired in respect of 
gender, these data were not subjected to statistical analysis.
Discussion
Forty-three cannabis users with additional cigarette consump-
tion and 42 tobacco smokers took part in the study. The groups 
were paired according to age but not according to gender. The 
inclusion and exclusion criteria were chosen for the following 
reasons. Eighteen was adopted as the lower age limit because 
in Switzerland people 18 years and older do not have to obtain 
their parents’ permission to participate in a study such as this. 
Twenty-ﬁve was chosen as the maximum age in order to limit 
variation in age. The use of other illicit drugs was chosen as an 
exclusion criterion to limit the results to those of cannabis 
alone. Pregnancy was chosen as an exclusion criterion because 
radiography was performed on the subjects. Weekly cannabis 
use was chosen as an inclusion criterion for the test group 
because Coffey et al. (2003) reported that the most important 
predictors of cannabis addiction are weekly cannabis use and 
regular tobacco smoking. As all cannabis users in our study 
smoked at least 10 cigarettes per day, control group subjects 
who smoked at least 10 tobacco cigarettes per day were se-
lected. Out of 15 examined risk factors to become a cannabis 
user, the following three were found to be the most important 
ones: tobacco smoking, accessibility of cannabis and pessimis-
tic health prospect. If these three factors are present the prob-
ability for cannabis use is 77% (Schmid 2000). The pacemaker-
hypothesis describes cannabis consumption as a consequence 
of precedent consumption of tobacco and alcohol (SFA-ISPA 
2004). All cannabis users and tobacco smokers had to have 
been using the substances for at least two years before the trial 
because this interval is sufﬁcient for the development of cari-
ous lesions.
Members of the test group started using cannabis at an aver-
age age of 15 years, which is in accordance with the results of 
Müller & Gmel (2002), i. e., that teenagers begin to use can-
nabis before the age of 16. Cannabis users were initially re-
cruited through advertisements in free daily newspapers. That 
more male (n = 28) than female (n = 15) cannabis users re-
sponded is in agreement with the results of Schmid et al. (2003) 
and Müller & Gmel (2002).
Urine samples were not obtained to verify cannabis use be-
cause Gmel (1998) showed that self-reported cannabis use is 
not distorted by denial tendencies. Furthermore, urine analy-
sis would only have ascertained whether participants were 
positive or negative for THC and would have provided no in-
formation on the frequency and intensity of cannabis use.
It was difﬁcult to balance the groups because all cannabis 
users recruited also smoked tobacco. Furthermore, 30% of po-
tential participants did not show up for their examination 
appointment. Advertisements were placed in free daily news-
papers to recruit age- and gender-paired tobacco smoking 
participants but the response was poor. Forty-two participants 
were eventually selected for the control group but there were 
fewer males (n = 14) than females (n = 28). It is unclear why the 
response of tobacco smokers to the advertisements was poor 
or why more females registered to participate in group B than 
in group A. Of 20–24-year-old Swiss residents, 42.2% smoke 
tobacco (SFA-ISPA 2004a); 39.9% of males and 34.8% of fe-
males smoke tobacco (Gmel et al. 2006). It is thus reasonable to 
assume that our widespread media advertisements would have 
been seen by a considerable number of tobacco smokers. Den-
tal awareness is very high in Switzerland. Of the Swiss popula-
tion, 75% visit a dentist once a year and 10% visit a dentist 
twice a year (Imfeld 2000). In our study, 74% of the control 
group reported having annual dental control visits. According 
to a survey conducted by the Swiss Dental Association, 90% of 
participants (n = 1125) were satisﬁed with their dentist and 
49% indicated that they would still visit the same dentist if 
they moved to a different suburb (Kuster et al. 2000). There-
fore, it is possible that for many tobacco smokers, the offer of a 
free dental consultation and bitewing radiographs may have been 
outweighed by a desire to be treated by their own dentists.
The groups were not paired in respect of education. In group A, 
apprenticeships prevailed, while in group B more participants 
had an academic education. Furthermore, tobacco consump-
tion was not paired between genders within groups. Neverthe-
less, the study reafﬁrmed that cannabis use is widespread ir-
respective of level of education, which corroborates the results 
of Müller & Gmel (2002).
There are no published clinical studies on the effects of can-
nabis per se on oral health. Silverstein’s test group consisted 
  Group A Group B                                  Gender 
    Males A Females A Males B Females B
 DFS 8.07 6.76 9.14 6.07 2.50 8.48
 DS 4.88 0.74 5.61 3.53 0.42 0.87
Tab. V DFS and DS in groups A and B
  Group A Group B                        Gender 
    Males A Females A Males B Females B
 D1–2 on smooth surfaces of molars 0.86 0.52 0.86 0.86 0.00 0.73
 D3–4 on smooth surfaces of molars 0.74 0.05 1.04 0.20 0.08 0.03
 D1–2 on smooth surfaces of anterior teeth 0.95 0.00 1.32 0.27 0.00 0.00
 D3–4 on smooth surfaces of anterior teeth 0.60 0.07 0.82 0.20 0.00 0.10
Tab. VI Detailed DS results for groups A and B
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of vegetarians who used other drugs in addition to cannabis; 
control group subjects did not use drugs or tobacco but were 
not vegetarians (Silverstein et al. 1978). Di Cugno compared 
subjects who used both cannabis and amphetamines with 
subjects who did not use these drugs (1979). The only existing 
reports on cannabis and dental health are literature reviews, 
not clinical studies. Therefore, our study is the ﬁrst clinical 
report on cannabis use and the prevalence of caries in smokers. 
Because of the small number of participants, who were not 
paired in respect of gender, the data were insufﬁcient to sup-
port deﬁnitive conclusions. Nevertheless, several noteworthy 
tendencies emerged.
The frequency of tooth brushing and dental visits differed 
highly signiﬁcantly (p < 0.0001) between groups. There was no 
difference in the consumption of high-sugar snacks but there 
was a signiﬁcant difference in the intake of sweet beverages 
(p x0.0078). Although these results suggest that cannabis users 
have a high risk of developing caries, plaque and gingival in-
dices did not differ between groups. The incidence of DFS did 
not differ between groups A and B (8.07 vs. 6.76, respectively). 
When DFS data of male participants alone were analyzed, the 
difference between groups was signiﬁcant (group A, 9.14; 
group B, 2.50; p = 0.0051). However, this statistic should be 
interpreted with caution because the number of males in the 
test and control groups differed (n = 28 and n = 15, respectively). 
On the other hand, the between-group difference in the inci-
dence of DS was highly signiﬁcant (p < 0.0001). More untreated 
lesions were present in group A than in group B. This may be 
responsible for the impression of private practitioners that 
cannabis users have more caries than those who do not use 
cannabis, because untreated carious lesions, especially those 
at low-risk locations such as smooth surfaces, are a more obvi-
ous sign of caries than restorations.
In cannabis users, carious lesions were most prevalent on 
smooth surfaces (Fig. 1). The DS results of our study were com-
pared with data from a 2006 epidemiological caries survey of 
Swiss military recruits (Table VII). In our study, cannabis users 
had a higher prevalence of caries than military recruits, when 
expressed as the number of DS on smooth surfaces. Caries le-
sions on smooth surfaces are indicative of high caries activity 
because these surfaces are easily brushed.
Statistical comparison of our data with that of the Swiss 
military recruit study was not done because participants in the 
latter study were representative of 20-year-old men and the 
dataset had a normal distribution of smokers and cannabis-
using participants.
Saliva ﬂow rates did not differ between groups (group A, 
1.8 ml/min; group B, 1.9 ml/min), nor did pH or buffer capac-
ity. Several authors have shown that salivation is reduced by 
atropine (Cho 2005, Darling & Arendorf 1992, Di Cugno 
1979, Grotenhermen 2001). In our study, 84% of the partici-
pants experienced a dry mouth after using cannabis and 91% 
felt thirsty, indicating that short-term hyposalivation occurs 
after using cannabis. There was no evidence of chronic hypo-
salivation, xerostomia or long-term reduction in buffer capacity 
or pH, even though 97% of the participants had used cannabis 
more than once weekly for more than two years. It would be 
of interest to examine saliva ﬂow rate immediately after can-
nabis consumption. However, a request for study participants 
to use cannabis at a speciﬁc time could be interpreted as mo-
tivating them to use cannabis, which is illegal according to 
Article 19 of the Swiss Health Statute (BetmG 2007). According 
to 81% of the participants, a dry mouth persisted for up to an 
hour after using cannabis; 19% reported that it lasted between 
2 and 6 hours. Of all cannabis users, 63% ate sweet food, 31% 
drank sweet beverages (soft drinks or noncarbonated sweet 
drinks) after using cannabis and 28% did not clean their teeth 
after using cannabis or before sleeping (most cannabis users 
consume cannabis and sweet foods or beverages during the 
evening). Such behavior increases the risk of caries and may 
be aggravated by a dry mouth.
Fig. 1 Carious lesions on smooth surfaces in an 18-year-old cannabis user.
 Males A Males B Swiss recruits 
 n = 28 n = 15 n = 606
D1–2 on smooth surfaces of molars 0.86 0.00 0.59
D3–4 on smooth surfaces of molars 1.04 0.08 0.09
D1–2 on smooth surfaces of anterior teeth 1.32 0.00 0.44
D3–4 on smooth surfaces of anterior teeth 0.82 0.00 0.12
Tab. VII Comparison of DS results of the present study and those of a 2006 survey of Swiss military recruits
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That smoking cannabis may increase the risk of developing 
cancer (Tashkin 1999) did not inﬂuence the participants’ at-
titude to the use of cannabis: 97% answered that they would 
not stop using cannabis despite the risk of cancer. Surprisingly, 
79% indicated that they would change their routine if can-
nabis were proven to affect their teeth, 44% answered that they 
would brush their teeth after consuming cannabis and sweet 
beverages or foods and 44% indicated that they would improve 
their oral hygiene.
The hypothesis that cannabis increases the risk of caries was 
not conﬁrmed by the results of this study. However, the differ-
ence between groups in the incidence of DS was highly sig-
niﬁcant. Cannabis users had considerably more open carious 
lesions than those who did not use cannabis. Short-term xe-
rostomia and consumption of cariogenic food and beverages 
after using cannabis may be responsible for the high incidence 
of caries on smooth surfaces. The cariogenic diet, reduced 
frequency of oral hygiene and rare dental control visits indi-
cate that the lifestyle of cannabis users makes an important 
contribution to the incidence of caries. Therefore, the combi-
nation of cannabis use and an unhealthy lifestyle increases the 
risk of caries on smooth surfaces. The ﬁnding that cannabis 
users indicated that they would change their oral hygiene if 
their addiction resulted in an increased risk of caries, suggests 
that oral health education by private practitioners and prophy-
laxis personnel would be a successful preventive measure. The 
effects of cannabis on oral health have not been thoroughly 
investigated. Further studies are needed to gain more insights 
into this interesting ﬁeld.
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Zusammenfassung
Im letzten Jahrzehnt hat sich der Cannabiskonsum unter 
Schweizer Jugendlichen fast verdoppelt. Empirische Beobach-
tungen aus der Privatpraxis lassen vermuten, dass Cannabis-
konsumenten mehr Karies haben als Nichtkonsumenten. In 
der vorliegenden Studie wird untersucht, ob regelmässiger 
Cannabiskonsum zu einem erhöhten Kariesrisiko führt. Die 
möglichen Ursachen (1) Hyposalivation und (2) Lifestyle wer-
den diskutiert.
43 Cannabis- und 42 Tabakkonsumenten (18- bis 25-jährig) 
wurden untersucht. Die Daten der Probanden wurden mittels 
standardisierten Fragebogens und klinischer Untersuchung er-
fasst.
Zwischen der Studien- und Kontrollgruppe gab es keine sig-
niﬁkanten Unterschiede bei den DFS-Werten, den Plaque- und 
Gingivaindices und der Speichelﬂiessrate. Bei den Cannabiskon-
sumenten waren der DS-Wert signiﬁkant erhöht (p = 0,0051), 
die tägliche Mundhygiene und Kontrollbesuche beim Zahnarzt 
signiﬁkant seltener (p < 0,0001) und der Konsum von Süssge-
tränken signiﬁkant häuﬁger (p = 0,0078). Die DS-Werte an Zahn-
glattﬂächen der männlichen Cannabiskonsumenten wurden 
verglichen mit den entsprechenden Daten der periodischen 
Rekrutenuntersuchung. Bei den Cannabiskonsumenten wurde 
deutlich mehr Glattﬂächenkaries festgestellt.
Gemäss den DFS-Werten kann kein erhöhtes Kariesrisiko bei 
Cannabiskonsumenten gegenüber der Kontrollgruppe nach-
gewiesen werden. Es liegt aber eine deutlich erhöhte Prävalenz 
von Glattﬂächenkaries gegenüber epidemiologischen Daten 
vor. Der Lifestyle verbunden mit einer kurzfristigen Hyposali-
vation nach THC-Konsum wird als mögliche Ursache ange-
nommen. Weitere Untersuchungen sollten den Einﬂuss des 
Cannabiskonsums auf die orale Gesundheit erforschen.
Résumé
En Suisse, la consommation de cannabis par les adolescents a 
presque doublé dans les dernières dix années. L’observation 
empirique des dentistes privés prête à croire que les consom-
mateurs de cannabis ont plus de caries que les non-consom-
mateurs. La présente étude examine si la consommation régu-
lière de cannabis augmente le risque de caries et discute les 
causes probables (1. l’hyposalivation ou 2. le style de vie de ces 
jeunes gens).
Un groupe de 43 consommateurs de cannabis et un groupe 
de contrôle de 42 consommateurs (de 18 à 25 ans) de tabac ont 
été examinés. Au moyen d’un questionnaire standardisé et 
d’un examen clinique les dates des participants ont été pri-
ses.
Il n’est pas résulté de différences signiﬁcatives en ce qui 
concerne les valeurs de DFS, ni pour ce qui est des tests de salive 
ainsi que des indices gingivaux et de plaque. Dans le groupe 
cannabis les résultats de DS étaient signiﬁcativement plus 
élevés (p = 0,0051), les résultats quant à l’hygiène orale quoti-
dienne et aux visites de contrôle chez le dentiste étaient si-
gniﬁcativement plus mauvais (p < 0,0001) et par ailleurs, les 
consommateurs de cannabis buvaient signiﬁcativement plus 
de boissons sucrées (p = 0,0078). Les résultats de DS aux surfa-
ces lisses pour les hommes du groupe cannabis ont été compa-
rés aux résultats corrélatifs de l’examen périodique de caries 
des recrues suisses. Chez les consommateurs de cannabis, on 
a constaté fortement plus de caries aux surfaces lisses.
Le DFS ne permet pas de constater un risque accru de caries. 
Cependant il y a une prévalence accrue de caries aux surfaces 
lisses face aux dates épidémiologiques. Comme source proba-
ble on agrée le lifestyle embranché à l’hyposalivation à court 
terme après avoir consommé THC.
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